← All companies
AVAI
Avaí Bio, Inc.
$0.13
+0.01 +4.13%
Key statistics
from XBRL data in SEC filingsMarket cap
$19.4M
Revenue (TTM)
$276K
Net income (TTM)
-$1.75M
EPS (TTM)
$-0.01
P/E ratio
—
Dividend yield
19.84%
Free cash flow
—
Cash
$23.1K
Total assets
$573K
Gross margin
-14.6%
52-week range
$0.11 – $0.80
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-K
Fiscal year ended 2026-03-31
Jul 14, 2026
8-K
Entered a material agreement
May 8, 2026
10-Q
Quarter ended 2025-12-31
Feb 12, 2026
8-K
Other events
Feb 9, 2026
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Entered a material agreement
Nov 4, 2025
8-K
Entered a material agreement
Sep 18, 2025
8-K
Other events
Sep 17, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
10-K
Fiscal year ended 2025-03-31
Jul 8, 2025
8-K
Terminated a material agreement
May 13, 2025
8-K
Entered a material agreement
Feb 27, 2025
10-K/A
Fiscal year ended 2024-03-31
Feb 19, 2025
10-Q
Quarter ended 2024-12-31
Feb 7, 2025
10-Q/A
Quarter ended 2024-09-30
Jan 21, 2025
10-Q/A
Quarter ended 2024-06-30
Jan 21, 2025
10-K/A
Fiscal year ended 2024-03-31
Jan 21, 2025
8-K
Entered a material agreement
Nov 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Entered a material agreement
Oct 31, 2024
8-K
Terminated a material agreement; Director or officer change
Sep 10, 2024
10-Q/A
Quarter ended 2024-06-30
Sep 3, 2024
10-Q
Quarter ended 2024-06-30
Aug 19, 2024
8-K
Entered a material agreement
Jul 22, 2024
8-K
Entered a material agreement; Director or officer change
Jul 15, 2024
10-K
Fiscal year ended 2024-03-31
Jul 3, 2024
8-K
Other events
Jun 5, 2024
8-K
Amended charter or bylaws
May 7, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change
Apr 26, 2024
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity
Apr 8, 2024
10-Q
Quarter ended 2023-12-31
Feb 14, 2024
8-K
Entered a material agreement; Director or officer change
Jan 31, 2024
8-K
Entered a material agreement; Director or officer change
Jan 19, 2024
8-K
Entered a material agreement
Dec 12, 2023
10-Q
Quarter ended 2023-09-30
Nov 17, 2023
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change
Nov 8, 2023
8-K
Took on a direct financial obligation; Unregistered sale of equity
Oct 6, 2023
8-K
Entered a material agreement; Unregistered sale of equity
Aug 18, 2023
10-Q
Quarter ended 2023-06-30
Aug 16, 2023
8-K/A
Entered a material agreement; Unregistered sale of equity; Director or officer change
Jul 26, 2023